Study of nerve cell regeneration on nanofibers containing cerium oxide nanoparticles in a spinal cord injury model in rats.

Authors:
Rahimi B; Behroozi Z; Motamednezhad A; Jafarpour M; Hamblin MR and 3 more

Journal:
J Mater Sci Mater Med

Publication Year: 2023

DOI:
10.1007/s10856-023-06711-9

PMCID:
PMC9944598

PMID:
36809518

View on PubMed View on PMC View Publisher
Journal Information

Full Title: J Mater Sci Mater Med

Abbreviation: J Mater Sci Mater Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Biomedical Engineering

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Antibacterial properties of marine algae incorporated polylactide acid membranes as an alternative …
Weitkamp JT; El Hajjami S; Acil Y and 10 more (2024) - Transparency Score: 3/6
Bioactive potential of Bio-C Temp demonstrated by systemic mineralization markers and immunoexpress…
Lopes CS; Delfino MM; Tanomaru-Filho M and 3 more (2024) - Transparency Score: 3/6
Doxorubicin-loaded PEG-CdTe QDs conjugated with anti-CXCR4 mAbs: a novel delivery system for extram…
Chen D; Chen F; Lu J and 3 more (2024) - Transparency Score: 3/6
Fabrication and characterization of 3D-printed composite scaffolds of coral-derived hydroxyapatite …
Kadi F; Dini G; Poursamar SA and 1 more (2024) - Transparency Score: 3/6
Flow affects the structural and mechanical properties of the fibrin network in plasma clots.
Eyisoylu H; Hazekamp ED; Cruts J and 2 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest MRH declares the following potential conflicts of interest. Scientific Advisory Boards: Transdermal Cap Inc, Cleveland, OH; Hologenix Inc. Santa Monica, CA; Vielight, Toronto, Canada; JOOVV Inc, Minneapolis-St. Paul MN; Sunlighten, Kansas City, MO; Consulting; USHIO Corp, Japan; Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany. Stockholding: Niraxx Light Therapeutics, Inc, Irvine CA; JelikaLite Corp, New York NY. The other authors declare no conflict of interest."

Evidence found in paper:

"Funding FR was supported by the IRAN University of Medical Sciences, Grant no. 97-4-32-13632. MRH was supported by US NIH Grants R01AI050875 and R21AI121700."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025